AMPHADASE is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Amphastar Pharmaceuticals, Inc.. The primary component is Hyaluronidase.
Product ID | 0548-9090_9d798dca-17f4-4ab4-9c1e-7d6f4f1bfa40 |
NDC | 0548-9090 |
Product Type | Human Prescription Drug |
Proprietary Name | AMPHADASE |
Generic Name | Hyaluronidase |
Dosage Form | Injection |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2004-10-26 |
Marketing Category | NDA / NDA |
Application Number | NDA021665 |
Labeler Name | Amphastar Pharmaceuticals, Inc. |
Substance Name | HYALURONIDASE |
Active Ingredient Strength | 150 [USP'U]/mL |
Pharm Classes | Endoglycosidase [EPC],Glycoside Hydrolases [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2004-10-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021665 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2004-10-26 |
Marketing Category | NDA |
Application Number | NDA021665 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2004-10-26 |
Marketing End Date | 2014-05-16 |
Ingredient | Strength |
---|---|
HYALURONIDASE | 150 [USP'U]/mL |
SPL SET ID: | 8396ea96-7cb5-4e26-87a4-90bca9c3c6dd |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0548-9090 | AMPHADASE | hyaluronidase |
51662-1555 | HYALURONIDASE | HYALURONIDASE |
17478-560 | Hydase | Hyaluronidase |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AMPHADASE 76632115 3057031 Live/Registered |
Amphastar Pharmaceuticals, Inc. 2005-02-25 |